Aberrant expressions or activity of USP7 have been implicated in a broad range of pathological conditions, including cancer, neurodegeneration, viral infections, and autoimmune disorders, consequently positioning it as an attractive pharmacological target. The gene discussed is USP7; the disease is autoimmune disease.